NA Tender by Employees State Insurance Corporation (esic) (GEM/2025/B/6109617)
Injection Durvalumab 500mg
Tender Timeline
Tender Title: Injection Durvalumab 500mg
Tender Reference Number: GEM/2025/B/6109617
Issuing Authority/Department: Ministry of Labour and Employment
Scope of Work and Objectives:
The primary objective of this tender is to procure Injection Durvalumab 500mg, which is a vital medication in the treatment of various types of cancers. The selected bidders will be responsible for supplying a total quantity of 3 units of the said injection. This procurement aims to ensure the availability of high-quality medication for patients in need, thereby supporting public health initiatives and improving treatment outcomes.
Eligibility Criteria:
Bidders seeking to participate in this tender must meet specific eligibility requirements, which include being a registered entity with a valid GST number. Additionally, bidders must possess relevant experience in supplying medical products, specifically oncology medications.
Technical Requirements:
The technical requirements for the injection include compliance with established quality and safety standards. Bidders are required to provide documentation that certifies the product's efficacy, shelf-life, and manufacturing processes, ensuring adherence to pharmaceutical regulations.
Financial Requirements:
All participating bidders must provide a bid price for the injection, which should reflect fair market value while maintaining profitability. Additionally, it is essential to detail any potential costs related to delivery and logistics in the bid submission.
Document Submission Details:
All documents must be submitted electronically through the designated online portal. Bidders should ensure that all submissions are complete, inclusive of required certifications and legal documents, to avoid disqualification.
Special Provisions:
This tender includes provisions that support Micro, Small, and Medium Enterprises (MSEs) and startups. Bidders classified as MSEs will benefit from preferential treatment during the evaluation process, encouraging participation and fostering growth within the sector.
Evaluation Process:
The evaluation of bids will be conducted based on a set of predefined criteria covering both technical and financial aspects. Bidders are advised to ensure compliance and demonstrate the quality of their products effectively to maximize their chances of selection.
Delivery Locations:
The injections must be delivered to designated healthcare facilities as specified post-award. Bidders should clearly outline their delivery capabilities and timelines in their submissions.
Contact Information:
While detailed contact information is not provided, bidders are encouraged to reach out through the online portal for any inquiries regarding the tender.
With a strong emphasis on quality and compliance, this tender aims to partner with reliable suppliers to ensure the provision of essential medical solutions for patient care.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
3 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity with a valid GST number. Bidders must also have demonstrable experience in supplying medical products, particularly oncology drugs. It is essential that bidders provide proof of compliance with pharmaceutical manufacturing standards, ensuring their ability to deliver quality products.
The technical specifications for Injection Durvalumab 500mg necessitate that all products comply with regulatory quality and safety standards set by health authorities. Bidders need to submit documentation that confirms the product’s efficacy, including batch testing reports. Compliance with Good Manufacturing Practices (GMP) must also be documented to ensure the integrity of the pharmaceuticals.
Bidders must provide a performance security as part of their submission to guarantee the fulfillment of contract obligations. This performance security is typically a percentage of the total bid amount and serves to protect against non-performance or defaults. Further details regarding the exact percentage will be specified in the evaluation criteria.
Documents should be submitted electronically through the designated online tender portal. Bidders must ensure that all important documents, including the necessary certificates and compliances, are submitted in the specified formats. Accepted document formats typically include PDF and Word documents, and bidders should ensure that their submissions are clear and legible.
MSEs participating in this tender are entitled to specific benefits that create a more favorable environment for smaller businesses. This includes preferential consideration during the evaluation process, which supports the overall growth and development of smaller enterprises within the healthcare sector. MSEs are also encouraged to offer competitive pricing to reinforce their stance in the market.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders